Acadian Asset Management »

Rapt Therapeutics shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $432k 17k 25.73
2025-06-30 $726k 91k 7.97

More positions owned by Acadian Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Mastercard Incorporated Cl A (MA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Booking Holdings (BKNG)
JPMorgan Chase & Co. (JPM)
Deutsche Bank A G Namen Akt (DB)
Ubs Group SHS (UBS)
Logitech Intl S A SHS (LOGI)
Broadcom Ord Shs (AVGO)
Telefonaktiebolaget Lm Erics Adr B Sek 10 (ERIC)

View all positions for Acadian Asset Management

Top funds holding Rapt Therapeutics

TCG Crossover Management
Foresite Capital Management VI
Rtw Investments
OrbiMed Advisors
Ikarian Capital
Boone Capital Management
Deep Track Capital
Vanguard Group
Nantahala Capital Management
Siren
Redmile Group
Soleus Capital Management
ADAR1 Capital Management
Fcpm Iii Services B.v.
Boothbay Fund Management

View all funds holding Rapt Therapeutics